Podcasts about Biomanufacturing

Global Market Insights predicts the precision fermentation market for food and beverage will grow from just about two billion in 2024 to 70 billion globally by 2034. That's a staggering combined annual growth rate of nearly 40%. Liberation Labs is pioneering a new approach to precision fermentation at scale that borrows a page from the pharmaceutical industries playbook. Co-founder and CEO, Mark Warner, joins us to get into: What exactly is precision fermentation? The challenge facing companies, particularly early-stage innovators, that Liberation Labs saw an opportunity to solve for with contract precision fermentation The company's recent announcement of its first customer for the Indiana facility, Vivici, what they will do for them and what's exciting about the partnership How Mark saw an opportunity in the pharmaceutical space that could be replicated in fermentation for agbioscience innovation Mark's journey to fundraise for Liberation Labs Reflecting on the decision to put their facility in Indiana for access to talent, corn and transportation The biggest opportunities for growth – not just for Liberation Labs – but for precision fermentation as an industry Biomanufacturing's importance to economic growth, but in urban and rural America What's ahead for Liberation Labs

Global Market Insights predicts the precision fermentation market for food and beverage will grow from just about two billion in 2024 to 70 billion globally by 2034. That's a staggering combined annual growth rate of nearly 40%. Liberation Labs is pioneering a new approach to precision fermentation at scale that borrows a page from the pharmaceutical industries playbook. Co-founder and CEO, Mark Warner, joins us to get into:  What exactly is precision fermentation? The challenge facing companies, particularly early-stage innovators, that Liberation Labs saw an opportunity to solve for with contract precision fermentation The company's recent announcement of its first customer for the Indiana facility, Vivici, what they will do for them and what's exciting about the partnership How Mark saw an opportunity in the pharmaceutical space that could be replicated in fermentation for agbioscience innovation Mark's journey to fundraise for Liberation Labs Reflecting on the decision to put their facility in Indiana for access to talent, corn and transportation The biggest opportunities for growth – not just for Liberation Labs – but for precision fermentation as an industry Biomanufacturing's importance to economic growth, but in urban and rural America What's ahead for Liberation Labs 

Send us a textWhat if we could revolutionize biotechnology by slashing antibody production costs by 70%? In a world where traditional mammalian cell cultures struggle with scalability and cost-effectiveness, an unexpected hero emerges from the depths of our oceans - microalgae.The use of microalgae in biotechnology is not just a novelty but a necessity, given the current demands for more efficient and cost-effective production methods. Muriel Bardor, co-founder, CEO and CSO of Alga Biologics, highlights a particularly startling statistic: microalgae can reduce the cost of antibody production by an impressive 70%. This innovation could revolutionize the biotechnology industry by making life-saving therapies more accessible.Here are 3 key takeaways from this podcast episode:Quality and Safety Assurance: By collaborating with virology experts and using advanced techniques like mass spectrometry, they ensure that their processes are virus-free and free from host-cell protein contamination. The company is paving the way for future developments despite the challenges of not having standard ELISA kits commercially available.Regulation and Industry Perception: Launching such transformative technology inevitably entwines with regulatory landscapes. Muriel and her company have begun discussions with the French regulatory agency, drawing optimism from the fact that similar plant-based products, such as glucocerebrosidase, have already paved the way in the market. This indicates a growing acceptance within regulatory bodies of alternative bioprocessing platforms, inspiring hope for microalgae's future in antibody production.Future Vision: Muriel hopes to break conservative barriers within pharmaceutical companies and promote the adoption of microalgae production. This offers not only cost-effective solutions but also holds potential for new treatment options, like for neuroblastoma.Check out the episode to hear Muriel's advice for aspiring scientists and the general public alike regarding the future of research and the well-being of our planet.Connect with Muriel Bardor:LinkedIn: www.linkedin.com/in/muriel-bardor-47953024Email: muriel.bardor@univ-rouen.frAlga Biologics: www.algabiologics.comNext step:Book a free consultation to refine your CMC strategy to propel your success: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotech

What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies, and is there too much capacity or is the market tight? Is biomanufacturing outsourcing up or down? Are biopharma companies outsourcing more or less? Plus the impact on evolving trade policy on biomanufacturing supply chains. Featuring: Eric Langer, MBA, Managing Partner & President, BioPlan Associates and Renaud Jacquemart, PhD, MBA, Senior Advisor, BioPlan AssociatesSupport the show

Send us a textThe world of biologics manufacturing is about to be transformed by a breakthrough that slashes antibody production costs by 70%. This revolutionary approach leverages the untapped potential of microalgae to deliver a sustainable, cost-effective solution that could make life-saving therapeutics more accessible than ever before. Enter microalgae, the star of this groundbreaking development.In this episode of the Smart Biotech Scientist, Muriel Bardor, the co-founder, CEO and CSO of Alga Biologics, shared insights into how her team's pioneering work with microalgae could redefine the landscape of immunotherapy.Here are some takeaways from her conversation with David Brühlmann:Green Revolution in Bioprocessing: Discover how microalgae can slash production costs by 70% and offer a sustainable alternative to traditional antibody manufacturing. Muriel explains how these photosynthetic organisms capture 7 tons of CO2 per kilogram of product - transforming antibody manufacturing both economically and environmentally.Rethinking Antibody Production: Learn why the conventional use of mammalian cells in antibody production is being challenged and how microalgae overcome the limitations of traditional methods, bringing life-saving drugs within reach for more people globally.Sustainable Impact: With a process that mirrors nature, Muriel's approach sets a new standard for eco-friendly biotech production. Find out how microalgae are changing not just the industry, but our world.We invite you to listen to this insightful conversation and explore how you can apply these groundbreaking ideas to your own work. Has Muriel's innovative approach inspired you? Share your thoughts or questions with us - we'd love to hear from you!If you are interested in antibody production, here is another episode worth listening:Episodes 47-48: Mastering Process Economics: Driving Down Costs in Antibody Production with Brian KelleyConnect with Muriel Bardor:LinkedIn: www.linkedin.com/in/muriel-bardor-47953024Email: muriel.bardor@univ-rouen.frAlga Biologics: www.algabiologics.comNext step:Book a free consultation to refine your CMC strategy to propel your success: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotech

Biomanufacturing takes center stage in this week's podcast! My guest is Bert Verbruggen from imec. Bert and I explore the challenges of biomanufacturing and how inline production process monitoring can help solve these issues. Bert and I also discuss new inline sensor developments developed by imec  and the value that artificial intelligence can bring in these systems.

Send us a textIn the fast-evolving world of biotechnology, the pursuit of efficiency and faster development has never been more critical. The computational tools and models currently being integrated into bioprocessing present a groundbreaking approach that promises radical shifts in drug development timelines and capabilities.In the second part of our conversation, Yossi Quint, founder and CEO of Ark, shows us that the horizon of bioprocessing is lined with possibilities that could revolutionize biotherapeutics accessibility, cost, and speed in pharmaceutical innovations.Here are three key takeaways you don't want to miss:De-risking with Simulation: Yossi shared how simulation models can drastically reduce risks by running many scenarios before actual implementation. This approach optimizes processes, lowers costs, and speeds up the development cycle.Transfer Learning in Bioprocessing: Discover the potential of leveraging data across different types of molecules! Although challenging, the ultimate goal is to apply data learnings from one process to others, maximizing efficiency and success rates.Patient Impact & Cost Reduction: At the heart of these innovations is the goal of quicker, more affordable drug production. By slicing down on both time and costs, computational tools not only help drugs reach the market faster but also make them more accessible to patients globally.With innovation at its core, the modern trajectory of bioprocessing is not simply about reaching scientific milestones but about profoundly transforming patient care and accessibility. This synergistic blend of technology and purpose crafts a future in which the biotechnology sector not only grows but also enriches countless lives around the globe.If you are interested in this topic, here are a few standout conversations on AI's impact on bioprocessing with some incredible experts:Episodes 131-132: Combining AI and Biomanufacturing for Sustainable, Cost-Effective Therapeutics with Reza FarahaniEpisodes 115-116: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy AgrestiEpisodes 111-112: AI Meets Biology: Why Domain Expertise Still Rules in the Age of Large Language Models with Lars BrandénEpisodes 107-108: From 1 Billion to 100: How AI is Cracking the Enzyme Discovery Code with David SchönauerEpisodes 95-96: AI in Bioprocess Development: The Game-Changer You Can't Ignore with Belma AlispahicConnect with Yossi Quint:LinkedIn: https://www.linkedin.com/in/yossi-quintArk: https://www.ark-biotech.comNext step:Wondering how to develop biomanufacturing processes with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biotherapeutics better, faster, at a fraction of the cost with our 1:1 Strategy Call. Book your call at https://stan.store/SmartBiotech/p/book-a-11-call-with-me-j4vhuo6t

Send us a textThe integration of AI into drug discovery has already led to groundbreaking advancements, uncovering patterns in vast datasets that were previously invisible to human researchers. Now, AI is set to revolutionize bioprocessing as well.In this episode of the Smart Biotech Scientist Podcast, Yossi Quint, founder and CEO of Ark, and David Brühlmann explore how AI and computational tools are reshaping bioprocess development. Yossi envisions a future where 90% of bioreactor experiments could be replaced by in silico simulations, dramatically accelerating time to market and increasing throughput.Key takeaways from the conversation with Yossi Quint:AI's Role in Drug Discovery & Bioprocessing: AI is already transforming drug discovery by identifying intricate patterns across millions of data points. Now, bioprocessing is undergoing a similar revolution, as computational tools simplify and streamline complex workflows.The Power of Hybrid Models: Yossi highlights the synergy between mechanistic models and AI-driven approaches, emphasizing how AI can fill gaps where traditional models struggle—especially in understanding complex cellular behaviors.Empowering Bioprocess Teams with AI: As AI accelerates drug discovery, bioprocessing must evolve to keep pace. Yossi discusses the importance of digital transformation in ensuring bioprocess teams can meet increasing demands and drive innovation forward.With AI-driven models, hybrid simulations, and increased digitization, the bioprocessing industry stands at the cusp of a new era. The convergence of data, science, and technology promises not only greater efficiency and accuracy but also a faster path to life-saving treatments for patients in need.If you want to learn more, here are a few standout conversations on AI's impact on bioprocessing with some incredible experts:Episodes 131-132: Combining AI and Biomanufacturing for Sustainable, Cost-Effective Therapeutics with Reza FarahaniEpisodes 115-116: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy AgrestiEpisodes 111-112: AI Meets Biology: Why Domain Expertise Still Rules in the Age of Large Language Models with Lars BrandénEpisodes 107-108: From 1 Billion to 100: How AI is Cracking the Enzyme Discovery Code with David SchönauerEpisodes 95-96: AI in Bioprocess Development: The Game-Changer You Can't Ignore with Belma AlispahicConnect with Yossi Quint:LinkedIn: https://www.linkedin.com/in/yossi-quintArk: https://www.ark-biotech.comNext step:Wondering how to develop biomanufacturing processes with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biotherapeutics better, faster, at a fraction of the cost with our 1:1 Strategy Call. Book your call at https://stan.store/SmartBiotech/p/book-a-11-call-with-me-j4vhuo6t

It could be argued that biology has always boiled down to chemistry, and that chemistry has always boiled down to physics. However, not many would deny that the fields of biology and chemistry are overlapping more than ever, with both leveraging computing methods, also more than ever. This conversation with Dr. Ramesh Jha, Technical Staff Member at Los Alamos National Laboratory (LANL), crosses biology, chemistry, and computing methods. The work of his biome team at LANL uses computational tools to inform the design of enzymes that are produced via PCR-based cloning and then expressed in microbes. They use fluorescent gene circuits in these microbes, along with flow cytometry, to screen these large libraries for advantageous gain-of-function variants. When they find an interesting mutation, they isolate it, sequence it, and produce and evaluate those biocatalytic enzymes for bioremediation, biomanufacturing, and other important applications. Ramesh makes this complex and interdisciplinary science approachable and gives hope to how it could help address problems of “forever chemicals” and other environmental and manufacturing challenges. Join us for this interesting and inspiring conversation.  Subscribe to get future episodes as they drop and if you like what you're hearing we hope you'll share a review or recommend the series to a colleague.  Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.

Send us a textArtificial Intelligence (AI) is transforming industries worldwide, and biotechnology is no exception. In bioprocess development, AI is proving to be a game-changer, accelerating workflows, optimizing processes, and driving innovation. On the Smart Biotech Scientist Podcast, Reza Farahani, founder and CEO of Catalyze AI, shares his insights on how AI is reshaping biomanufacturing and the future of the industry.As AI continues to integrate into bioprocessing, the role of scientists is evolving. Farahani envisions a future where scientists collaborate with AI to enhance efficiency. One of Catalyze AI's exciting innovations is an agentic root cause analysis tool, designed to automate troubleshooting. Instead of spending hours on manual analysis, scientists will receive AI-generated reports outlining probable causes of failures—allowing them to focus on high-level decision-making.What you'll learn in this episode:Exciting Advances in AI: Farahani highlights the potential of Artificial General Intelligence (AGI)—AI that can generate ideas through analogy, much like humans do. Imagine an AI system recognizing a successful method in the petroleum industry and applying those principles to biomanufacturing. This kind of cross-disciplinary innovation could unlock groundbreaking efficiencies.Leadership Principles in AI-Driven Biotech Startups: Farahani takes an unconventional approach to leadership. Unlike corporate environments where avoiding mistakes is crucial, he encourages his team to embrace failure early on. "I want to see you make a mistake in the first month," he tells new hires. By removing the fear of failure, his team can experiment, think creatively, and drive true innovation—an essential mindset for biotech startups breaking new ground.Advice for Aspiring Biotech Entrepreneurs: Farahani's advice is simple: find a problem, develop a unique solution, and take action. He urges scientists to identify small inefficiencies that can be scaled and optimized. Equally important is being open to failure and iterating quickly to refine solutions. Success comes from starting, adapting, and continuously improving.As we stand on the brink of a biomanufacturing revolution, the real opportunity lies in combining AI with biologics. While AI often dominates the conversation, Farahani emphasizes that biologics remain underhyped. The true breakthroughs will come from leveraging AI to solve real-world challenges in biomanufacturing, leading to significant efficiencies and industry-wide advancements.For those passionate about this field, staying connected with thought leaders like Reza Farahani and keeping up with the latest innovations is key. As AI and biologics continue to converge, the future of bioprocessing holds unprecedented potential for transformation and progress.Curious about how AI is transforming bioprocessing? Discover how industry experts are driving innovation to shape the future of this field.Episodes 111 and 112: AI Meets Biology: Why Domain Expertise Still Rules in the Age of Large Language Models with Lars BrandénEpisodes 107 and 108: From 1 Billion to 100: How AI is Cracking the Enzyme Discovery Code with David SchönauerConnect with Reza FarahaniLinkedIn: https://www.linkedin.com/in/reza-farahani-/Catalyze AI: https://www.catalyzeai.com/Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biotherapeutics better, faster, at a fraction of the cost with our 1:1 Strategy Call.

Send us a textThe real-world applications of AI in biomanufacturing are transformative. From reducing drug development timelines to optimizing production yields, AI is making biomanufacturing more efficient and cost-effective. This, in turn, enhances global access to life-saving therapies. As AI continues to evolve, its potential to drive even greater innovations in biologics manufacturing becomes increasingly promising.In the latest episode of the Smart Biotech Scientist Podcast, David Brühlmann speaks with Reza Farahani, founder and CEO of Catalyze AI, about the profound impact of AI on biomanufacturing. They discuss how AI is reshaping drug development, reducing costs, and simplifying complex biomanufacturing processes - bringing us closer to a future where life-saving drugs are as accessible as smartphones.Why You Should Tune In:AI's Role in Democratizing Biomanufacturing: One of the core missions of Catalyze AI is to democratize the sophisticated knowledge that currently resides mostly within top pharmaceutical companies. By leveraging AI to improve bioprocess development, Farahani aims to bridge the knowledge gap between academia and industry, thereby reducing the cost and accelerating the development of new therapeutics. This democratization of bioprocess knowledge could potentially revolutionize the accessibility and affordability of life-saving drugs.How AI Optimizes Bioprocess Development: AI has the unique ability to manage and analyze complex, convoluted data sets much more efficiently than humans. Reza explains how transformer models—similar to the ones used in natural language processing tasks by ChatGPT—can be utilized to predict and optimize various steps in the biomanufacturing process. These models can learn and make predictions based on past data, enabling a significant reduction in the time and resources required for process development.Solving the Scale-Up Challenge: Scale-up remains one of the most challenging aspects of bioprocess development, often plagued by delays and inefficiencies. AI can immensely help by leveraging data from both small and large-scale biomanufacturing processes to predict optimal conditions. However, given the complexity and high cost associated with scale-up experiments, Reza envisions a future where distributed, small-scale biomanufacturing units could replace large-scale facilities. This would not only reduce costs but also enhance flexibility and resilience against process failures.AI is not just accelerating drug development—it's reshaping the entire biomanufacturing landscape. Don't miss this insightful conversation on how AI is driving the future of biotech.As we stand at the intersection of AI and biomanufacturing, the possibilities are limitless. With continued advancements, we may soon witness a paradigm shift where drug production becomes more decentralized, efficient, and tailored to global healthcare needs. The future of biotech is being written now—are you ready to be part of it?Interested in exploring more about AI's impact on bioprocessing? Check out what other experts in the field are doing to drive innovation in this space.Episodes 119 and 120: Innovating Protein Purification Using Synthetic Organelles and AI with Haotian GuoEpisodes 115 and 116: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy AgrestiConnect with Reza FarahaniLinkedIn: https://www.linkedin.com/in/reza-farahani-/Catalyze AI: https://www.catalyzeai.com/Wondering how to develop biomanufacturing processes with peace of mind? Schedule your free assessment to propel your success:

Humanity is grappling with the effects of climate change, and one urgent challenge is ensuring a stable and sustainable supply of protein for human consumption and agricultural use. That's where molecular farming, an innovative technology that uses the power of plants to produce high-quality proteins, may present a unique solution. Tune into Sustainability In Your Ear for a conversation with Maya Sapir-Mir, co-founder and CEO of PoLoPo, to explore how molecular farming could transform food production, and make potato chips better for us.We'll discuss the science behind PoLoPo's approach, the potential for reducing the environmental footprint of protein production, and what this means for the future of global food security. Genetic modification remains a subject of debate. While extensive studies confirm its safety for human consumption, concerns about its impact on biodiversity persist. Simply replacing one monoculture with another would not address biodiversity loss or solve global food production's more profound systemic challenges. One thing is sure: how we eat in the future will be different. Just as a meal today looks nothing like one from 1960, 1900, or 1770, the food landscape of 2040 will evolve—likely toward a more plant-centric, sustainable plate. However we get there, it will shape not just our diets but the future of our planet. Learn more about PoLoPo at https://polopo.tech Subscribe to Sustainability in Your Ear on iTunes and Apple Podcasts.Follow Sustainability in Your Ear on Spreaker, iHeartRadio, or YouTubeCheck out previous Earth911 interviews about food innovationEarth911 Podcast: Alter Eco Foods CEO Keith Bearden Is All-In On Regenerative Chocolate FarmingBest of Earth911 Podcast: Re:Dish CEO Caroline Vanderlip on Creating a Circular Food Service SystemEarth911 Podcast: Safe Catch CEO Sean Wittenberg on Making Seafood SustainableBest of Earth911 Podcast: Wild Planet Founder & CEO Bill Carvalho on Making Seafood SustainableEarth911 Podcast: Farmstead's Pradeep Elankumaran on Building Sustainable Food Delivery

David Heller of C16 Biosciences speaks about biomanufacturing technology and products and business strategy. Adam Lawrence co-hosts. OUTLINE (00:00) Introduction (00:32) Career path (03:13) Origin of C16 Biosciences (07:12) Palm oil agriculture (10:06) C16 Bio's core technology (11:14) IP strategy (16:22) Products (18:50) Competitors (21:02) Value ecosystem  (24:05) Positioning  (25:32) Criticisms of precision fermentation  (28:56) Technoeconomics and cost drivers (33:25) Resources and inputs (35:27) Capital costs (38:31) Challenges (41:29) GMO (42:15) Regulatory landscape (45:08) Risks (51:17) Vision

Doug Friedman joins the podcast to talk about one of the toughest challenges in biotech—how to survive long enough to actually make an impact. As the head of BioMADE, he's on a mission to build a bioindustrial manufacturing ecosystem that doesn't just rely on wishful thinking and a single grant check. He explains why most biotech startups get only "one shot on goal" (spoiler: they miss, they're done) and how we can fix that. Think of it like debugging a bad DNA sequence—you need iteration, not instant perfection. Doug also discusses how government funding is shaping the future of biomanufacturing, why biology today is where semiconductors were in the ‘80s, and why scaling biology might just need its own version of Moore's Law. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at www.messaginglab.com/groweverything  Chapters: 00:00:00 – Fail Fast or Fail Forever – Why biotech startups need more than one shot on goal 00:00:27 – AI Shake-Up – DeepSeek changes the game (and the stock market) overnight 00:01:01 – China vs. AI – What a hedge fund, government crackdowns, and new algorithms have in common 00:02:19 – Power Hungry AI – Why data centers might outgrow the energy grid before we're ready 00:03:36 – DeepSeek's Disruption – What it means for AI, efficiency, and the future of computing 00:04:13 – Innovation Under Pressure – How limitations create the best breakthroughs 00:05:46 – Mind Reading? – The wild world of telepathy research and what it means for biotech 00:07:45 – Quantum Strangeness – Exploring dimensions beyond what we can see 00:09:17 – Longevity Hacks – The Brian Johnson experiment: biohacking or billion-dollar placebo? 00:12:48 – Biomanufacturing is Booming – Why the future of production is biological 00:28:35 – PFAS Panic – 3M halts production, and microelectronics scrambles for solutions 00:30:53 – BioMADE's Master Plan – How industry collaboration is making biomanufacturing real 00:36:56 – Government Meets Biotech – Bridging public and private sectors for impact 00:38:44 – The Bioeconomy is Here – What it means for industries beyond biotech 0:42:29 – Talk to Your Legislators – How to get policymakers to care about biotech 00:46:08 – The Hardest Part of Biomanufacturing – What innovators need to overcome 00:50:42 – Biomanufacturing's Future – The biggest opportunities waiting to be unlocked 00:52:46 – Final Thoughts – Wrapping up lessons from the frontier of biotech Links and Resources: BioMADE Homeworld Collective (Apply today!) The Climate Biotech Podcast DeepSeek Wipes $1 Trillion from Tech Share Prices The Telepathy Tapes Don't Die, The Man Who Wants to Live Forever Rapamycin General Probiotics Antheia Schmidt Sciences Liberation Labs Topics Covered:  biomanufacturing, collaboration, public private partnerships, distributed biomanufacturing, longevity biotech, telepathy, tech  Have a question or comment? Message us here: Text or Call (804) 505-5553  Instagram  / Twitter / LinkedIn / Youtube / Grow Everything Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

Noah Helman, co-founder of Industrial Microbes, unpacks how his team is giving ethanol a glow-up as a renewable feedstock for creating advanced polymers and sustainable carbon fibers. With a decade of experience in the trenches of biomanufacturing, Noah discusses how they're engineering microbes to work smarter, not harder, tackling the challenges of cost, scale, and environmental impact. From leveraging industrial partnerships to envisioning a future where waste becomes the ultimate raw material, Noah delivers sharp insights with a side of microbial magic, proving that biology is not just life—it's a powerhouse of innovation. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠ Chapters: 00:00:00 - Prelude to Progress: The Challenge of Unique Equipment 00:00:21 - Oil, Politics, and the Biomanufacturing Tug-of-War 00:01:58 - From Biofuel Bust to Synthetic Biology Boom 00:03:59 - A Pledge Against Plastics: Aquarium Insights 00:05:35 - Woolly Mammoths and Capitalist Dinosaurs 00:08:11 - TikTok Drama: Perplexity's Unlikely Bid 00:12:29 - Ethanol: From Gas Tank to Biomanufacturing Hero 00:15:00 - Meet Noah Helman: Biomanufacturing Pioneer 00:18:00 - Scaling Up: The Chicken-and-Egg of Biomanufacturing 00:22:45 - Breaking Bottlenecks: Innovations in Equipment Access 00:27:00 - Collaborating for Carbon Fiber: Partnerships in Progress 00:30:27 - Spinning Carbon: Fiber Meets Sustainability 00:34:28 - Cracking the Code of Biomanufacturing Bottlenecks 00:36:51 - Waste Not, Want Not: The Power of Circular Inputs 00:42:34 - Futurecasting Biomanufacturing and Bioeconomies 00:45:03 - Next-Gen Biology: Enzymes, AI, and Big Data 00:50:58 - Closing the Loop: Microbial Magic and Future Frontiers Episode Links: iMicrobes The ROI of Waste  Beyond Petrochemicals BioMADE ARPA-E  First Bight Ventures Biowell  (accelerator program) Colossal biosciences raises $200M at 10B valuation Perplexity bids for TikTok  Arc Institute partners with NVIDIA to accelerate computational biomedical research Topics Covered: Biomanufacturing, acrylic acid, acrylonitrile, carbon nanofibers, industrial microbes, biotech startups, spaceships, accelerators, synbio investments  Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠  / ⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

Joško Bobanović of Sofinnova Partners speaks about bioeconomy, industrial biotech, and biomanufacturing. Adam Lawrence co-hosts. OUTLINE (00:00) Introduction (00:34) Education and career path (02:21) Sofinnova Partners (04:28) Investment strategy (06:34) Terminology (08:45) Industrial biotech history and evolution (14:06) Competitive strategies for bio startups (16:55) End applications – fuels, food, pharmaceuticals, materials (21:23) Value ecosystem and participants (24:57) Drivers (27:15) Business models, platforms, products (33:05) Success stories (36:17) Future of industrial biotech and bioeconomy

NINA TANDON Nina Tandon is a remarkable person, who is currently Co-Founder and CEO of EpiBone, a biotech company that grows bone and cartilage for skeletal reconstruction which just recently completed human trials reconstructing mandibles; the lower jaw is the largest and strongest bone in the face. Her life and accomplishments are inspiring and is deeply thoughtful, multi-dimensional and extremely driven. A great episode to kick off 2025, Happy New Year to all! She grew up on Roosevelt Island on the East River in New York City, and showed interest in science as a child when, her siblings suffered from eye conditions. They were encouraged to try various science experiments: Nina took apart TVs, built giant Tinkertoy towers, played with static solved complex puzzles, and dabbled in community theatre, poetry, and sewing. She studied French, Hindi and Italian, runs marathons, and enjoys metal-smithing and being a yoga instructor. EpiBone has raised millions in investor funding and has received such distinctions as the World Economic Forum's 2015 Technology Pioneer, named one of the 100 most exciting start-ups in New York City by Business Insider. Nina has been recognized as one of the 100 Most Creative People in Business by Fast Company Magazine; an Ernst & Young Winning Women and Goldman Sachs' 100 Most Intriguing Entrepreneurs, among others. Nina started her career as an electrical engineer. Then while studying abroad on a Fulbright scholarship, she worked on an electronic nose to “smell” lung cancer. This ignited her passion for healthcare and changed the course of her career. She went back to school, earning a master's in bioelectrical engineering from Massachusetts Institute of Technology (MIT), and two advanced degrees from Columbia University – an MBA in healthcare entrepreneurship and a PhD in Biomedical Engineering. With decades of experience as both a scientist and entrepreneur, Nina is a loud voice that raises  awareness on  the field of tissue engineering. She has done a number of TED Talks, has published in Forbes magazine, and was featured on the Netflix series “Human: The World Within". In 2022, she offered  policy perspectives at the White House Summit on Biotechnology and Biomanufacturing. RELATED LINKS Epibone Wikipedia Columbia Board Visitor TED Talks Crain's Women in Health GENERAL INFO| TOP OF THE GAME: Official website: https://topofthegame-thepod.com/ RSS Feed: https://feed.podbean.com/topofthegame-thepod/feed.xml Hosting service show website: https://topofthegame-thepod.podbean.com/ Javier's LinkTree: https://linktr.ee/javiersaade  SUPPORT & CONNECT: LinkedIn: https://www.linkedin.com/showcase/96934564 Facebook: https://www.facebook.com/profile.php?id=61551086203755 Twitter: https://twitter.com/TOPOFGAMEpod Subscribe on Podbean: https://www.podbean.com/site/podcatcher/index/blog/vLKLE1SKjf6G Email us: info@topofthegame-thepod.com   THANK YOU FOR LISTENING – AVAILABLE ON ALL MAJOR PLATFORMS

Adam Lawrence of AGL.BIO speaks about bioeconomy and biomanufacturing. OUTLINE (0:00) Introduction (00:38) Education and career (03:23) Challenges and barriers in biomanufacturing  (04:46) Bioeconomy terminology (08:52) Value of biomanufacturing and comparative advantage  (14:18) Actual and potential mpact (18:12) Chemical companies (19:38) Drivers (20:37) Value ecosystem and participants (23:08) Financing mechanisms (25:17) Mergers and acquisitions  (26:08) Subsegments – fuels, chemicals, food, pharmaceuticals (32:01) Waste stream valorization (34:05) Sentiment, stigma, and media

Lauren Coyle, Commissioning Editor, speaks with Dhruv Sareen, Executive Director at Cedars-Sinai Biomanufacturing Center, and Johnathan Rodriguez, Quality Control Manager at Cedars-Sinai Biomanufacturing Center, about the roles of in-process controls, method validation, risk management, and automation in biomanufacturing. They will highlight strategies to ensure product safety, consistency, and regulatory compliance for cell and gene therapy products.

Send us a textAre you ready to dive into the cutting-edge world of biomanufacturing? In this episode, strategic consultant James Ryall unveils the staggering potential of bio-based products to revolutionize industries. From cultured meat to human breast milk, discover how cells are becoming the ultimate manufacturing facilities.James shares invaluable insights on scaling challenges, regulatory hurdles, and the critical importance of early preparation for biotech startups. Learn why biomanufacturing is poised to transform up to 60% of consumer goods and how to stay ahead in this rapidly evolving field.Gain expert strategies to:Navigate scaling and regulatory challenges with confidenceCreate bio-based products that outperform traditional alternativesTap into the immense opportunities in non-clinical biomanufacturingWhether you're a seasoned bioprocessing expert or a curious entrepreneur, this episode will ignite your passion for the biotech revolution. Tune in now and discover how to ride the wave of biomanufacturing innovation!Connect with James Ryall:LinkedIn: https://www.linkedin.com/in/james-ryallWebsite: https://www.jamesryall.comNext Steps:Wondering how to develop biologics with clarity and precision? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Contact us at https://bruehlmann-consulting.com

Send us a textDr. Leonard Tender, Ph.D. is a Program Manager in the Biological Technologies Office at DARPA ( https://www.darpa.mil/staff/dr-leonard-tender ) where his research interests include developing new methods for user-defined control of biological processes, and climate and supply chain resilience.Prior to coming to DARPA, Dr. Tender was a principal investigator and led the Laboratory for Molecular Interfaces in the Center for Bio/Molecular Science and Engineering at the U.S. Naval Research Laboratory. There, among other accomplishments, he facilitated numerous international collaborations with key external stakeholders in academia, industry, and government and his highly interdisciplinary research team, comprised of electrochemists, microbiologists, and engineers, is widely recognized for its many contributions to the field of microbial electrochemistry.Dr. Tender earned a doctorate degree in analytical chemistry from the University of North Carolina, Chapel Hill; a bachelor's degree in chemistry from the Massachusetts Institute of Technology; completed a post-doctoral fellowship in the Department of Chemistry from the University of California, Berkeley; and served as a visiting scientist in the Stanford University Department of Chemistry. Dr. Tender co-founded the International Society for Microbial Electrochemistry and Technology and is a recipient of the Arthur S. Flemming Award, which honors outstanding federal employees, by the George Washington University's Trachtenberg School of Public Policy and Public Administration.#Darpa #Biomanufacturing #QuantumBiology #QuantumComputing  #NavalResearchLaboratory #MicrobialElectrochemistry #DefenseAdvancedResearchProjectsAgency #Bioelectronics #TissueRegeneration #UnderseaEnergy #BreathableArmors #EdibleMacronutrients #Lubricants #Adhesives #TacticalFibers #PotableWater #Plastic #OrbitalManufacturing #Extremophiles #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textIn this captivating episode, host David Brühlmann welcomes James Ryall, a strategic consultant with over two decades of experience in cell biology and regenerative medicine. From his groundbreaking work in skeletal muscle research to revolutionizing cultured meat production, James shares his fascinating journey through academia and industry.Discover how he's now helping biotech startups align their technical strategies with commercial outcomes, accelerating their path to market.You will gain invaluable insights on:Navigating the transition from academia to industryScaling cell production from lab quantities to industrial volumesIdentifying and pivoting to the right target market for biotech innovationsDon't miss this eye-opening discussion on simplifying bioprocessing and bringing game-changing products to life. Tune in now to supercharge your biotech career!Connect with James Ryall:LinkedIn: https://www.linkedin.com/in/james-ryallWebsite: https://www.jamesryall.comNext Steps:Wondering how to develop biologics with clarity and precision? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Contact us at https://bruehlmann-consulting.com

The future of biomanufacturing. In it we cover the emerging $4T bioeconomy, nature's ability to manufacture products, AI's acceleration of scientific discovery, China's quest for biological supremacy, and rethinking sustainability. Edward Shenderovich is CEO of Synonym, prior he was both an investor and entrepreneur, founding commercial real estate company Knotel where he raised over $400M and managed 200 locations across 4 continents. As an investor he founded Kite Ventures as well as Essential Capital, which include Delivery Hero and Fyber as their investments, both reaching IPO. Uniquely, Edward is also an accomplished Poet, having published multiple books in his native Russian. Sign up for new podcasts and our newsletter, and email me on danieldarling@focal.vcSee omnystudio.com/listener for privacy information.

Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

Send us a textWhat if your biomanufacturing facility could run itself, optimize its own processes, and operate non-stop? This isn't science fiction – it's the cutting-edge reality Professor Massimo Morbidelli is helping to create.In this captivating episode, the bioprocessing pioneer unveils how AI, continuous manufacturing, and revolutionary machine learning techniques are transforming the industry landscape.As a Professor Emeritus at ETH Zurich and Politecnico di Milano, and a co-founder of ChromaCon (now YMC) and DataHow, Massimo Morbidelli has been at the forefront of bioprocess innovation. He is currently the recipient of the ERC Advanced Grant Continuous Digitalisation of Bioprocesses (CoDiBio) at the Aristotle University of Thessaloniki.Discover how transfer learning is revolutionizing process development across molecules and scales, dramatically reducing time-to-market for new biologics. Learn why the integration of computer science and biology is crucial for staying competitive in the rapidly evolving biopharma landscape.You will gain invaluable insights onSlashing development costs,Maximizing productivity through 24/7 operationsLeveraging interdisciplinary knowledge to solve complex bioprocessing challengesAll are essential skills for thriving in the next era of biomanufacturing.Tune in now and revolutionize your approach to biopharma innovation!Connect with Massimo Morbidelli:Email: massimo “dot” morbidelli “at” polimi “dot” itNext Steps:Wondering how to develop biologics with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Contact us at https://bruehlmann-consulting.com

Send us a textImagine a world where biologic drugs are produced faster, cheaper, and with unprecedented precision.In this episode, we dive into that future with Professor Massimo Morbidelli, a trailblazer in bioprocessing innovation. As a Professor Emeritus at ETH Zurich and Politecnico di Milano, and a co-founder of ChromaCon (now YMC) and DataHow, Massimo Morbidelli has been at the forefront of bioprocess innovation. He is currently the recipient of the ERC Advanced Grant Continuous Digitalisation of Bioprocesses (CoDiBio) at the Aristotle University of Thessaloniki.From his groundbreaking work in continuous chromatography to spearheading AI-driven manufacturing, Morbidelli's 25-year journey has reshaped the biotech landscape.Discover how initial industry skepticism transformed into widespread adoption of continuous processing and machine learning. Prof. Morbidelli shares insights on his current project: a fully automated, end-to-end manufacturing process for plasmid DNA production.You will gain invaluable insights into:The evolution of continuous bioprocessing and its impact on productivity and yieldHow digitalization and machine learning are optimizing process development and manufacturingThe potential of transfer learning to dramatically reduce time-to-market for new biologicsDon't miss this opportunity to learn from a true visionary in the field.Tune in now to unlock the secrets of next-generation biomanufacturing and stay ahead of the curve in this rapidly evolving industry.Connect with Massimo Morbidelli:Email: massimo “dot” morbidelli “at” polimi “dot” itNext Steps:Wondering how to develop biologics with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessmentDevelop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Contact us at https://bruehlmann-consulting.com

Space is on the verge of major changes within the next four years. Join Izzy as she chats with Kirsten Whittingham, the new President of Max Space about the disruption her company is leading in new space station inflatable modules providing affordable scalable modules for in-space habitation, manufacturing, research labs, space farms, tourism, sports, and entertainment. https://getmaxspace.com/ CHAPTERS 01:13 Introduction of Kirsten Whittingham, President of Max Space 02:32 Building a cake and contracts Kirstn's journey to space via space camp 09:20 Max Space 13:21 Max Space Founders - Aaron Kemmer and Maxim de Jong 20:03 Manufacturing in space - What is the difference between manufacturing in space and manufacturing on Earth 21:15 Biomanufacturing of human organs and retinas 24:53 Cosmic Girls Foundation 30:44 Diversity in culture and background experience to bring different perspectives and different solutions 32:42 Space needs you - space needs all kinds of professions Outreach of space 33:48 Marketing through thought leadership with conferences by speaking on panels and sponsoring, then building trust further with news releases, websites, and social media. 37:09 Importance of outreach 40:06 Marketing and outreach challenges 44:35 Websites and social media 45:08 Having a professional marketing from the beginning 47:53 Future outlook for space 50:11 Final thoughts of the day Cosmic Girls Foundation - https://www.cosmicgirls.org/ Space Camp - https://www.rocketcenter.com/SpaceCamp Embry-Riddle University - https://erau.edu/ Genesis 1 and 2 Bigelow Expandable Activity Module (BEAM) on the International Space Station Made in Space Small Sat 2024 - https://smallsat.org ABOUT IZZY Izzy's website - https://izzy.house Author of Space Marketing: Competing in the new commercial space industry AND Space Marketing: Spaceports on Amazon and Audible - https://bit.ly/Space-Marketing Podcast host for Space Marketing Podcast - https://spacemarketingpodcast.com Organizer for Space for Kentucky Roundtable - https://spaceforkentucky.com Learn more about your ad choices. Visit megaphone.fm/adchoices

The U.S. can't have a vibrant “bio-based” manufacturing sector without an equally strong source of domestic materials to support it.

Episode Description: Karl and Erum have an informative conversation about the importance of networking. They discuss the philosophy behind building meaningful professional connections and share effective networking strategies. From insights into the concept of networking as an extension of human curiosity to tips like dividing and conquering at events, Karl and Erum give a comprehensive guide on enhancing your networking skills. They also talk about the idea of being generous and genuinely interested in others to foster stronger, more impactful relationships. Be sure to tune in if you're looking to improve your networking approach and build a robust professional network! Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠ Chapters: 00:00:00 Introduction to Networking and Podcast Feedback 00:00:32 Innovative Breakthroughs in Biomanufacturing 00:02:20 DNA Data Storage and the Fascinating World of Aerobiome Mapping 00:06:23 Lanzatec's Game-Changing Carbon Capture Collaboration 00:08:33 Networking Strategies: Stories from the Trenches 00:10:45 Dividing and Conquering at Networking Events 00:12:58 The Power of Authentic Connections 00:15:30 Making the Most of Professional Gatherings 00:17:45 The Role of Generosity in Networking 00:22:59 Discovering Your Interests and Finding the Right Events 00:29:20 Understanding Dunbar's Number: The Key to Effective Networking 00:33:54 Redefining Your Approach to Networking 00:38:49 Philosophical Insights: Networking in the Modern Age 00:43:26 Cultural Differences in Networking: A Global Perspective 00:44:19 Wrap-Up and Engaging with Our Audience Topics Covered: business, networking, biotech, synbio, relationship building, sales, partnerships, social engineering Episode Links: Networking Part 1 episode Mapping The World's Fungi from Air Samples Lanzatech and Coty collaboration on carbon capture fragrance Electric Skin Never Eat Alone book Dunbar's Number, maintaining 150 friends Gore company maxes at 150 per plant.  5/25/50: The Secret of the Best Networker Top books on how to network and build relationships Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

Episode Description: Karl and Erum discuss the fascinating world of biomanufacturing with Michele Stansfield from Cauldron. They explore the groundbreaking potential of precision fermentation and its ability to revolutionize food, fiber, and fuel production. Michele shares insights on Cauldron's innovative hyper fermentation technology, which offers a more sustainable and cost-effective alternative to traditional methods. The discussion also touches on the company's ambitious plans to build smaller, smarter biomanufacturing facilities globally, and the need for sustainable solutions in the face of growing food insecurity and environmental challenges. Tune in to learn how Cauldron is poised to transform the future of biomanufacturing and address critical global issues! Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠ Chapters: 00:00:00 - Sustainability: What Consumers Really Do 00:00:21 - Karl and Erum's Holiday Adventures and Special Replay 00:00:56 - Exclusive Replay: The Biomanufacturing Cloud Unveiled 00:02:34 - Dive into Biomanufacturing with Edward Shenderovich 00:04:42 - Why the World Desperately Needs More Biomanufacturing 00:06:02 - Overcoming the Biggest Hurdles in Biomanufacturing 00:08:28 - What Biomanufacturing Can Learn from Other Industries 00:10:45 - Capital Challenges: Building Large-Scale Facilities 00:12:00 - The Biomanufacturing Cloud: Making Production Accessible 00:14:30 - Tech Transfer: Streamlining Production Processes 00:16:10 - Standardizing Biomanufacturing: Why It Matters 00:18:00 - Case Study: Success Stories in Biomanufacturing 00:20:15 - Market Friction: Bridging the Gap Between Science and Production 00:22:34 - Game-Changing Tools and Insights from Synonym 00:26:41 - Synonym's Vision for the Future of Biomanufacturing 00:29:00 - Sneak Peek: Inside Synonym's First Biomanufacturing Facility 00:29:08 - Designing the Future: Facility Challenges and Strategies 00:31:34 - How Standardization is Revolutionizing Biomanufacturing 00:33:12 - Can We Retrofit Old Factories for Biomanufacturing? 00:35:53 - Why Consumer Education is Key to Biomanufacturing Success 00:37:26 - Biomanufacturing's Potential Environmental Breakthroughs 00:40:04 - What's Next? Trends and Innovations in Biomanufacturing 00:42:48 - The Future is Small: Distributed and Miniaturized Production 00:45:33 - Wrapping Up: Key Takeaways and Future Outlook Topics Covered: biotech, bioengineering, precision fermentation, continuous fermentation, hyperfermentation, australia, orange Episode Links: Enter to win free Oobli Chocolate  Cauldron Ferm  CISRO Commonwealth Scientific and Industrial Research Organization Australia's National Science Agency Main Sequence Ventures Boston Bioprocess Biobase EU Liberation Labs Agronomics  Blue Horizon Planetary Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

Episode Description: Since it's a holiday week, Karl and Erum are presenting a special replay of Edward Shenderovich's episode. Edward Shenderovich, a seasoned entrepreneur and visionary in the biomanufacturing space, takes us through his journey into the heart of biotechnology and its potential to reshape industries. Edward discusses the inception of Synonym and its mission to revolutionize biomanufacturing by creating a cloud infrastructure that accelerates the path towards sustainable and profitable production. Through a conversation that spans entrepreneurship, the complexities of biology, and the future of biotech innovation, Edward shares invaluable insights into the challenges and opportunities that lie ahead in harnessing the power of biomanufacturing for global benefit. This episode is a deep dive into the intersection of technology, biology, and business, illuminating the path forward for startups and established companies alike in the rapidly evolving biotech landscape. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠ Chapters: 00:00:00 - Sustainability: What Consumers Really Do 00:00:21 - Karl and Erum's Holiday Adventures and Special Replay 00:00:56 - Exclusive Replay: The Biomanufacturing Cloud Unveiled 00:02:34 - Dive into Biomanufacturing with Edward Shenderovich 00:04:42 - Why the World Desperately Needs More Biomanufacturing 00:06:02 - Overcoming the Biggest Hurdles in Biomanufacturing 00:08:28 - What Biomanufacturing Can Learn from Other Industries 00:10:45 - Capital Challenges: Building Large-Scale Facilities 00:12:00 - The Biomanufacturing Cloud: Making Production Accessible 00:14:30 - Tech Transfer: Streamlining Production Processes 00:16:10 - Standardizing Biomanufacturing: Why It Matters 00:18:00 - Case Study: Success Stories in Biomanufacturing 00:20:15 - Market Friction: Bridging the Gap Between Science and Production 00:22:34 - Game-Changing Tools and Insights from Synonym 00:26:41 - Synonym's Vision for the Future of Biomanufacturing 00:29:00 - Sneak Peek: Inside Synonym's First Biomanufacturing Facility 00:29:08 - Designing the Future: Facility Challenges and Strategies 00:31:34 - How Standardization is Revolutionizing Biomanufacturing 00:33:12 - Can We Retrofit Old Factories for Biomanufacturing? 00:35:53 - Why Consumer Education is Key to Biomanufacturing Success 00:37:26 - Biomanufacturing's Potential Environmental Breakthroughs 00:40:04 - What's Next? Trends and Innovations in Biomanufacturing 00:42:48 - The Future is Small: Distributed and Miniaturized Production 00:45:33 - Wrapping Up: Key Takeaways and Future Outlook Topics Covered: challenges and opportunities in biomanufacturing, the importance of location and economics in biomanufacturing, future directions and innovations in the field, environmental impacts of biomanufacturing, the role of AI in optimizing biomanufacturing processes Episode Links: 65. Scaling Cells, Dreaming Big: The Biomanufacturing Cloud with Synonym's Edward Shenderovich Synonym (company site) State of Global Fermentation Report 2023 (download) Pow Bio (company site) BCG Report: Synthetic Biology Is Getting Closer to Industrial Scale (link) McKinsey Report: Investing in the Data Center Economy (link) Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media

Dr. Daniel Stone speaks with Drs. Mario Mietzsch and Robert McKenna from the University of Florida to discuss a recent article published in the Biomanufacturing in Gene and Cell Therapy special issue of Molecular Therapy Methods & Clinical Development by Drs. Mietzsch, McKenna, and colleagues titled Production and characterization of an AAV1-VP3-only capsid: An analytical benchmark standard. If you enjoy today's conversation, you'll also enjoy the upcoming ASGCT Policy Summit in Washington, DC, September 23-24.  This can't-miss event brings together policymakers and gene and cell therapy experts, including FDA leaders Julie Tierney and Dr. Nicole Verdun, to discuss the latest policies impacting this rapidly evolving field.  Register now at https://www.asgct.org/PolicySummit for invaluable insights on navigating the regulatory landscape.  In This Episode: Dr. Daniel StoneAssociate Editor-in-Chief of Molecular Therapy Methods & Clinical Development and Senior Staff Scientist, Infectious Disease Sciences, Vaccine and Infectious Disease Division at Fred Hutch Cancer Center Dr. Mario MietzschAssistant Scientist, Department of Biochemistry and Molecular Biology, University of Florida Dr. Robert McKennaProfessor and Director of the Center for Structural Biology, Department of Biochemistry and Molecular Biology, University of Florida 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0.www.scottbuckley.com.auShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

Uncover the innovative world of Synonym Bio, pioneering the next wave of sustainable biomanufacturing.Ep.#97 Tech4Climate Podcast by Startup BasecampPART 1: Meet the founder: Edward Shenderovich, the Co-founder & CEO of Synonym BioIn this episode of the Tech 4 Climate Podcast, I had the pleasure of speaking with Edward Shenderovich, the Co-founder & CEO of Synonym Bio, a trailblazer startup reshaping how we approach biomanufacturing with their "fermentation farms," creating ecosystems where synthetic biology can flourish.Edward Shenderovich, has charted a fascinating path through the realms of mathematics and philosophy, eventually steering his way into entrepreneurship and synthetic biology. His unique journey is marked by a blend of rigorous analytical skills and a deep philosophical understanding of technology's role in society. In our conversation, Edward unpacks the story behind Synonym Bio's groundbreaking digital tools, Capacitor and Scaler, and their transformative impact on the biomanufacturing industry. We'll focus into the challenges of navigating complex biological processes, the strategic thinking driving the company's growth, and how Synonym Bio aims to streamline the biotech production pipeline. Let's look into the nexus of innovation, sustainability, and the vision to build a more resilient future! PART 2: My secret sauce: (AVAILABLE TO MEMBERS ONLY - More info on our site)Building a genuine relationship with investors is equally important as having a strategic financial approach. Investors prioritize sincerity over hard sell—they're experienced in discerning authenticity. Regarding work-life balance, Edward emphasizes the importance of good sleep.

Episode Description: Erum and Karl welcome renowned environmentalist, Murali Muthuswamy. He is the founder and chairman of Jananom Private Limited, founder of Elive Biotherapeutics USA, and advisor to Natural Nutrition. Murali explains the urgent and complex challenges of sustainable development. He also talks about the intricate balance required to meet the needs of the present without compromising the future. Exploring innovative solutions, Murali shines a light on groundbreaking technologies and community-driven initiatives that are paving the way for a more sustainable world. This episode not highlights the critical issues but also inspires action, making it a must-listen for anyone interested in shaping a sustainable future. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠ Chapters: 00:00:00 - Opening Welcome to Grow Everything: Diving into Today's Special Guest Intro with Shelby Newsad 00:01:29 - Global Explorations: Uncovering Insights from Australia and Brazil 00:04:15 - Climate Biotech Symposium: A Nexus of Networking and Innovation 00:11:32 - Sustainable Innovations: Case Studies of Success 00:13:12 - Trailblazing Paths: Murali Muthuswamy's Entrepreneurial Saga 00:17:04 - From Vision to Reality: Scaling Sustainable Solutions 00:20:21 - The Role of Policy in Supporting Eco-Innovations 00:24:42 - At the Cutting Edge: Synthetic Biology's Battle Against Cancer 00:26:50 - Green Tech: Harnessing Renewable Energy Sources 00:30:33 - Eco-Friendly Manufacturing: Reducing Carbon Footprints 00:34:10 - The Economic Impact of Sustainable Practices 00:38:39 - Innovative Approaches to Oncology: Smart Microorganisms at Work 00:40:17 - Redefining Pharmaceuticals: The Synthesis of Biology and Drug Development 00:41:52 - Exploring the Promise of Living Biotherapeutics 00:45:03 - Digital Meets Biological: Transforming Research and Applications 00:50:12 - India's Ambitious Stride into Biomanufacturing 00:52:20 - Fostering Future Leaders in Biotech Entrepreneurship 00:55:50 - In the Limelight: Breakthroughs from Leading Biotech Firms 00:58:44 - Converging Worlds: Digital Integration in Modern Biotechnology 01:01:15 - Conclusion: Celebrating the Advances in Biotech Innovation Episode Links: Compound VC (link) Genspace  (link) Evolva (link) India Institute of Chemical Technology (link) Department of Biotechnology in India (link) Biocon (link) Tata Elxsi (link) Avisa Myko (link) Synonym Biomanufacturing (link) Scaling Cells, Dreaming Big: The Biomanufacturing Cloud with Synonym's Edward Shenderovich (link) Homeworld Collective (link) Cascade Biocatalysts (link) SentiBio (link) Encellin (link) Get $300 off ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Synbiobeta tickets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (May 6-9 in San Jose, CA) using promo code: Grow Everything Topics Covered:  synthetic biology, synbio, bioengineering, organism engineering, microbiology Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Support here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

The Central Carolina Community College (CCCC) BioWork program trains students for a career with biomanufacturing organizations like Pfizer.

Episode Description: Karl and Erum are diving into the world of Squitex, an innovative fabric born from the unique properties of squid teeth, with Melik Demirel, co-founder of Tandem Repeat and Huck endowed chair professor at Penn State. Melik shares his journey from exploring the depths of protein science to pioneering a sustainable solution that stands to revolutionize the textile industry. As they unpack the creation and potential of Squitex, Melik's insights illuminate the intersections of marine biology, biotechnology, and material science. This episode not only explores the technical marvels of Squitex, including its self-healing capabilities and environmental benefits, but also lays out Melik's mission to blend scientific rigor with sustainability. Today you are sure to gain an appreciation for the meticulous research and innovative thinking driving the development of textiles that are not just eco-friendly but are paving the way for a new era in fashion and beyond. This discussion is a testament to the power of interdisciplinary collaboration and the endless possibilities when nature's ingenuity meets human innovation. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠ Chapters: 00:00:00 Welcome: Biotechnology's Transformative Power 00:01:07 Pop Culture Meets Science: Analyzing OK Go's Creativity 00:03:09 The Complexity of Biological Systems Explained 00:04:44 The Global Landscape of Biomanufacturing 00:06:00 Navigating the Crossroads of Biotech and Global Regulations 00:11:33 The Riches of the Ocean: BioProspecting's Promise 00:15:02 Squitex: A Leap in Sustainable Fabric Technology 00:19:32 Bridging Fashion and Sustainability with Squitex Innovation 00:22:18 The Self-Healing Marvel: Unpacking Squitex's Unique Properties 00:26:32 How Squitex Contributes to a Greener Planet 00:31:11 The Role of Plants in the Future of Biomanufacturing 00:32:02 The Critical Steps of Processing Biomanufactured Products 00:34:06 Overcoming the Hurdles of Scaling Production 00:36:50 Merging Traditional Textile Techniques with Modern Bioinnovation 00:38:36 From Research Lab to Real-World Impact 00:43:22 Educating the Next Generation on Biomanufacturing's Role 00:46:30 The Broad Implications of Biomanufactured Solutions 00:48:54 Looking Ahead: The Expansion of Biomanufacturing 00:52:39 Wrapping Up: The Untapped Potential of Biotech Episode Links: Tandem Repeat (link) OkGo Music Videos (link) Melik Demirel on Forbes Technology Council (link) Melik Demiel at Penn State (link) Self-Healing Research in Nature (link) BIOMADE - US biomanufacturing initiative (link) Aachen Institute (link) TITK Research Institute (link) Get $300 off ⁠⁠⁠⁠⁠⁠⁠Synbiobeta tickets⁠⁠⁠⁠⁠⁠⁠ (May 6-9 in San Jose, CA) using promo code: Grow Everything Topics Covered:  biomaterials, sustainability, biodegradablility, compostibility Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Support here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

Dr. Beth Conerty helps lead business development for the Integrated Bioprocessing Research Lab at the University of Illinois. She's also the Regional Innovation Officer for the iFAB Tech Hub, an initiative created by the Biden administration to strengthen manufacturing innovation in America. Tune in to hear about the research area of bioprocessing and how it can transform the central Illinois economy! ADDITIONAL LINKS- VISIT http://researchpark.illinois.edu/podcast/ for our entire catalog of episodes.

Recorded at SCbio's 2024 annual conference, hosts Heather and Matthew welcome Sarah Glaven, a research biologist and the Assistant Director of Biotechnology and Biomanufacturing for The White House Office of Science and Technology Policy. We have an insightful conversation on America's bioeconomy and bioliteracy and dive into President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bio economy, which established the National Biotechnology and Biomanufacturing Initiative or NBBI. Listen to episode 185 now!

This is CC Pod - the Climate Capital Podcast. You are receiving this because you have subscribed to our Substack. If you'd like to manage your Climate Capital Substack subscription, click here. Disclaimer: For full disclosure, Pow.bio is a portfolio company at Climate Capital, where Michael works as a General Partner.CC Pod is not investment advice and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any investment decision.Don't miss an episode from Climate Capital!In the latest CC Pod episode, join Michael Luciani and guest Shannon Hall , co-Founder and CEO of Pow.bio as they discuss Pow.bio's innovative role in sustainable biomanufacturing. Through advanced synthetic biology, they're revolutionizing traditional fermentation, leading the industry toward a more sustainable future.Pow.bio aims to revolutionize fermentation processes. This is a critical area as it plays a key role in sustainable manufacturing, especially in the chemical and pharmaceutical industries. Their approach combines synthetic biology and machine learning to scale up this technology for a broader impact.Shannon shares the challenges she faced during the startup's early days. From developing effective communication cadence to handling HR, she discusses how she and the team navigated these hurdles by focusing on shared goals and maintaining a commitment to making a difference in the industry.The conversation also delves into the fundraising process, where Shannon shared her experiences and lessons. She emphasized the importance of resilience and adaptability. She also highlighted the value of understanding investors' perspectives and needs, and how effective communication can help navigate potential issues.Shannon's journey is a testament to the power of passion and resilience in driving innovation and making a significant impact in the world of synthetic biology. Her insights serve as an inspiration for other founders and those interested in the intersection of biology and technology.Visit pow.bio to learn more! Get full access to Climate Capital at climatecap.substack.com/subscribe

Excited to have a conversation with Martin Permin, Founder and CEO of Invert. The company is on a mission to transform biomanufacturing through advanced software and data analytics. We discuss the founding of Invert, what capabilities they give their customers, and the importance of biomanufacturing to grow biological products like proteins, enzymes, and specialty chemicals. Production from bioreactors allows us to produce important medicines, sustainable materials, biofuels, and other products that will shape our future. However, it's incredibly complex with so many variables to control. A perfect place for software to shine. And where Invert comes in. Martin started the company in 2021 to help biomanufacturers manage, analyze, and optimize their data. The Invert platform integrates with bioreactors and databases to capture bioprocessing data. It then applies AI and analytics to surface insights and identify process improvements. Just ID'ing ways to improve, or avoiding bad runs, in bioprocessing is a major pain point for companies trying to develop or scale up their manufacturing. Invert makes it seamless to manage these processes across an organization. Before starting Invert, Martin had an entrepreneurial career with roles at Airbnb and Hive. Then saw an opportunity to bring a modern software solution to the biotech industry. Invert's features really exemplify this vision. The platform provides tools for planning experiments, monitoring bioprocess runs as they happen, analyzing results across projects, modeling scale-up, and collaborating with partners. It works to eliminate all the manual workflows that hold companies back. Since launch, Invert has had strong traction within synthetic biology and industrial biotech setting up expansion to biopharma customers. For many, it's become mission-critical for managing their data and enabling team collaboration. In our conversation, Martin talks about how customers use Invert at various stages of their product development. From optimizing algae strains to make renewable chemicals. To developing synthetic meats and helping customers compare runs across sites. Martin also shares his vision for the future of biomanufacturing and software for biotech. Where he paints a picture on how data-driven science can lead to more accessible medicines, foods, and materials.

Episode Description: Ross McBee, co-founder and CSO of TomTex, takes us into the innovative world of biomaterials, showcasing his commitment to sustainability and eco-friendly solutions. By turning waste shrimp shells into versatile, biodegradable materials, McBee is not just proposing an alternative to traditional textiles but is pioneering a future where fashion and environmental stewardship go hand in hand. This discussion zeros in on the potential of biomaterials to reshape industries, emphasizing the importance of a holistic approach to sustainability that includes both ecological care and fair employment practices. McBee's vision for a more sustainable and ethically conscious world is both inspiring and a call to action for industries to adopt more regenerative practices. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠www.messaginglab.com/groweverything⁠⁠ Chapters: 00:00:00 - Dive into the World of Biomaterials 00:01:14 - Recap & Insights on Biomanufacturing 00:03:00 - The Indian Bioeconomy: A Closer Look 00:05:46 - AI's Role in Society & the Job Market 00:10:26 - Meet Ross McBee & The Vision Behind TomTex 00:12:00 - Unveiling TomTex: The Science of Sustainable Materials 00:16:18 - Traditional Textiles vs. TomTex's Sustainable Solutions 00:20:31 - Origin Story: How TomTex is Changing the Game 00:29:07 - Envisioning the Future with Biomaterials 00:32:49 - Innovation in Action: Designing New Materials 00:34:51 - Navigating the Challenges of Global Supply Chains 00:37:33 - The Journey to Biodegradability with TomTex 00:43:05 - Embedding Sustainability in Business DNA 00:48:11 - TomTex's Breakthrough in Fashion Sustainability 00:54:04 - The Boundless Potential of Biomaterials 00:59:43 - Wrapping Up: TomTex's Sustainable Vision & Impact Episode Links: Tomtex (link) Breaking The Cost Barrier on Biomanufacturing (link) Ankur Capital Deep Tech Report (link) Erum's 23andMe LinkedIn post (link) Scott Galloway's Corporate Ozempic (link) Newlab (link) Brooklyn Navy Yard (link) Get $300 off ⁠⁠Synbiobeta tickets⁠⁠ (May 6-9 in San Jose, CA) using promo code: Grow Everything Topics Covered:  biomaterials, sustainability, biodegradablility, compostibility Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Support here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

Episode Description: Edward Shenderovich, a seasoned entrepreneur and visionary in the biomanufacturing space, takes us through his journey into the heart of biotechnology and its potential to reshape industries. Edward discusses the inception of Synonym and its mission to revolutionize biomanufacturing by creating a cloud infrastructure that accelerates the path towards sustainable and profitable production. Through a conversation that spans entrepreneurship, the complexities of biology, and the future of biotech innovation, Edward shares invaluable insights into the challenges and opportunities that lie ahead in harnessing the power of biomanufacturing for global benefit. This episode is a deep dive into the intersection of technology, biology, and business, illuminating the path forward for startups and established companies alike in the rapidly evolving biotech landscape. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠www.messaginglab.com/groweverything⁠ Chapters: 00:00:00 - Meet Edward: Entrepreneur & Biomanufacturing Visionary 00:00:24 - Edward's Entrepreneurial Odyssey: From Tech to Biotech 00:02:13 - Pioneering Shift: Edward's Dive into Biomanufacturing 00:04:23 - Biotech's Role in Shaping Future Food Systems 00:06:00 - Economics Unpacked: The Biomanufacturing Business Model 00:10:18 - Envisioning Tomorrow: The Broad Horizon of Biomanufacturing 00:13:10 - Scaling Hurdles: Growing Pains in Biomanufacturing 00:15:39 - Inside Synonym: Spearheading the Biomanufacturing Revolution 00:19:26 - Decoding Biomanufacturing: The Criticality of Techno-Economic Analysis 00:23:53 - Synonym's Journey & Vision: Forging the Future of Biotech 00:25:39 - Evolving Spaces: The Next-Gen Biomanufacturing Facilities 00:27:25 - Diverse Futures: Exploring Biomanufacturing Types & Needs 00:34:21 - Eco-impact: Biomanufacturing's Environmental Footprint 00:36:59 - AI's Role in Refining Biomanufacturing Processes 00:40:01 - Culinary Revolution: Cultivated Meats & Bioproducts 00:42:28 - Final Insights: What Lies Ahead for Biomanufacturing Episode Links: Synonym (company site) State of Global Fermentation Report 2023 (download) Pow Bio (company site) BCG Report: Synthetic Biology Is Getting Closer to Industrial Scale (link)  McKinsey Report: Investing in the Data Center Economy (link) Get $300 off ⁠Synbiobeta tickets⁠ (May 6-9 in San Jose, CA) using promo code: Grow Everything Topics Covered:  challenges and opportunities in biomanufacturing, the importance of location and economics in biomanufacturing, future directions and innovations in the field, environmental impacts of biomanufacturing, the role of AI in optimizing biomanufacturing processes, the potential for distributed and miniaturized manufacturing, advancements in bioreactor technologies, and the intersection of biomanufacturing with sustainability goals Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠Instagram⁠⁠⁠⁠ / ⁠⁠⁠⁠TikTok⁠⁠⁠⁠ / ⁠⁠⁠⁠Twitter⁠⁠⁠⁠ / ⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠ / ⁠⁠⁠⁠Youtube⁠⁠⁠⁠ / ⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠ Email: groweverything@messaginglab.com Support here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On today's episode of the Business of Biotech, Lees sits down with Scorpius VP of commercial operations Steve Lavezoli for a frank conversation on the ups, downs, and expectations of a biotech + CDMO relationship. In addition to contracts and master service agreements, the pair walk us through the day-to-day execution of the partnership and responsibilities of those involved in it. If you're considering signing on with an outsourced manufacturing partner, or thinking about making a switch, you won't want to miss this episode. Subscribe to the #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!

Are you struggling to unlock the full potential of Process Analytical Technology (PAT) in biomanufacturing?Look no further!Join us for a game-changing conversation with Abhijeet Satwekar, an Innovation Manager at Merck Guidonia-Rome, Italy.Discover how PAT can revolutionize your decision-making, accelerate development timelines, and propel your biotech company to new heights.Key Learnings:Decoding PAT's Impact: Abhijeet provides unprecedented insights into how PAT technologies revolutionize decision-making in real-time, ensuring unparalleled control over manufacturing processes. Discover the race towards achieving real-time release and initiatives propelling patient-centric value.Fast-Tracking Development Timelines: Explore the potential of PAT in risk reduction by gaining step-by-step insights into process evolution. Uncover how comprehensive data capture can slash Quality Control testing lead times, potentially transforming weeks into mere days.Mastering PAT Implementation Strategies: Abhijeet advocates for simplicity in adopting PAT, commencing with a strategic voice-of-customer approach. Delve into critical process points, select PAT tools judiciously, and establish equivalence with traditional methods for seamless integration.Get ready to harness the power of PAT and gain a competitive edge in the digital transformation of biomanufacturing.Don't miss out on this opportunity to become a PAT expert and unlock endless possibilities for success!Connect with Abhijeet Satwekar:LinkedIn: https://www.linkedin.com/in/abhijeetsatwekar/

Wondering how you can leverage the immense potential of the rapidly evolving world of digital transformation in biomanufacturing?Join us as we explore the frontiers of technology and innovation with Abhijeet Satwekar, Innovation Manager at Merck Healthcare.Discover how cutting-edge digital technologies are revolutionizing bioprocesses, optimizing efficiency, and ensuring consistent product quality.Key Learnings:Process Optimization: Discover the transformative impact of digital technologies on optimizing processes from small-scale studies to large-scale manufacturing, ensuring robustness and consistent product quality.Digital Twin and Efficiency: Explore the realm of digital twins, simulations, and business intelligence tools that revolutionize batch scheduling, planning, and overall bio-manufacturing efficiency.Balancing Innovation and Regulation: Understand the delicate balance between embracing new technologies and satisfying regulatory requirements. Abhijeet provides insights into maintaining confidence through a hybrid model that combines digital insights with traditional process analytical technology.Tune in for a wealth of knowledge that transcends the boundaries of traditional and digital realms in the quest for groundbreaking biologics.Connect with Abhijeet Satwekar:LinkedIn: https://www.linkedin.com/in/abhijeetsatwekar/

Join Matt DeCoursey and Dennis Ridenour, CEO of BioNexus KC, as they delve into the world of biomanufacturing tech hubs, unraveling how BioNexus KC is transforming Kansas City into a nexus for biomanufacturing and digital health. Uncover challenges, from advocating for biomanufacturing to securing funding, and witness how KC's collaborative spirit propels the region's ascent as a tech hub for biomanufacturing.   Find Startup Hustle Everywhere: https://gigb.co/l/YEh5   This episode is sponsored by Full Scale: https://fullscale.io   Learn more about BioNexus KC: https://bionexuskc.org  See omnystudio.com/listener for privacy information.

Did you know that New Jersey is rapidly emerging as a powerhouse of innovation, especially in the life sciences and technology sectors?Join us in this enlightening episode with Kara Moore from the New Jersey Economic Development Authority (NJEDA), as she unveils the state's strategic initiatives and opportunities for businesses and investors.

Disclaimer: For full disclosure, Gelatex s is a portfolio company of Climate Capital, where Jenny works as a Managing Partner.CC Pod is not investment advice and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any investment decision.Subscribe to CC Pod wherever you listen to your podcasts:In the latest episode of the Climate Capital podcast, hosted by Jenny Kan - GP of Climate Capital's Bio Fund - we had the privilege of delving into the world of Gelatex. This innovative materials technology company, led by co-founders Mari-Ann and Märt-Erik, is on a mission to revolutionize various industries by offering sustainable and versatile solutions. TL;DL (too long; didn't listen):Gelatex's proprietary technology, developed in Estonia, enables the efficient production of bio-based nanofibers. These nanofibers possess unique properties that can be harnessed across a wide range of applications: from eco-friendly leather-like textiles to cultured meat, wound care, bio-based filtration materials, and tissue engineering.Initially starting with a focus on eco-friendly textiles, Mari-Ann and Märt-Erik realized the immense potential of their nanofiber technology and made a pivotal decision to pivot in 2020. This move allowed them to explore new avenues and applications, broadening their impact on multiple industries.Mari-Ann and Märt-Erik emphasize the importance of putting together a skilled and passionate team that aligns with their vision. Their dedication to finding the right people has been instrumental in overcoming obstacles and achieving milestones.Looking ahead, Gelatex has ambitious plans to expand their production capabilities. They aim to establish a certified production facility, paving the way for widespread adoption of their groundbreaking materials. By continuing to disrupt industries and provide sustainable alternatives, Gelatex envisions a future where high-tech materials reshape lab-grown products. Get full access to Climate Capital at climatecap.substack.com/subscribe

Elliot Roth is the founder of Spira, a company that engineers algae for sustainable, healthier, and cost-effective industry applications. He is passionate about using algae to solve some of the world's most pressing problems, such... Source

Harry's guests this week are Sri Kosaraju, the CEO of Inscripta, and Richard Fox, a former Inscripta scientist who just rejoined the company as its SVP of Synthetic Biology. In reabsorbing Infinome—the Inscripta spinout Fox described to Harry in a spring 2021 episode of the show—Inscripta is placing a big bet on biomanufacturing, the creation and fermentation of genetically customized microbes that can pump out medical, agricultural, and nutraceutical products, and more. Inscripta had previously focused on a benchtop "bio-foundry" machine called Onyx that that makes programmed edits to bacterial or yeast cells at thousands of different points in their genome in parallel. Now it's pivoting away from selling the machine and instead focusing on becoming a power user of its own technology. Its ultimate plan is market multiple biomanufactured products, starting with a synthetic form of bakuchiol, an alternative to the anti-aging compound retinol.For a full transcript of this episode, please visit our episode page at http://www.glorikian.com/podcast Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.